Brain

Amplifire Transforms Epic Training: New KLAS Case Study Shows 75% Reduction in Training Time

Adaptive Learning Platform Delivers Personalized EHR Training at Scale, Achieving Higher Provider Satisfaction and Dramatic Efficiency Gains as reported by…

4 weeks ago

Vista AI Secures $29.5M in Series B Funding as Health Systems Back Automated MRI Scanning

Hospitals including Cedars-Sinai and Intermountain Health join Khosla Ventures and others to expand AI-driven scanning across anatomiesPALO ALTO, Calif., Jan.…

4 weeks ago

Vista AI Secures $29.5M in Series B Funding as Health Systems Back Automated MRI Scanning

Hospitals including Cedars-Sinai and Intermountain Health join Khosla Ventures and others to expand AI-driven scanning across anatomiesPALO ALTO, Calif., Jan.…

4 weeks ago

Wonder Sciences Launches WondermedAI™ Provider Pilot During J.P. Morgan Healthcare Conference

Advanced AI Clinical Operating System Addresses Fragmentation in Mental Healthcare Through Coordinated, Data-Informed CareSAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ --…

4 weeks ago

Wonder Sciences Launches WondermedAI™ Provider Pilot During J.P. Morgan Healthcare Conference

Advanced AI Clinical Operating System Addresses Fragmentation in Mental Healthcare Through Coordinated, Data-Informed CareSAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ --…

4 weeks ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

- Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ACCESS…

4 weeks ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

- Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ACCESS…

4 weeks ago

Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico

Sarasota, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the “Company”) today announced that it will…

4 weeks ago

RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study

APOLLO BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company…

4 weeks ago